<DOC>
	<DOCNO>NCT01186445</DOCNO>
	<brief_summary>The purpose study determine whether intracoronary injection morphine chlorhydrate effective limit ischemia-reperfusion lesion percutaneous coronary angioplasty patient acute myocardial infarction ( AMI ) .</brief_summary>
	<brief_title>Morphine In Acute Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>1 . Acute Myocardial Infarction less 6 hour define 1. prolonged chest pain ( &gt; 15 min ) 2. association ST elevation 1mm two contiguous lead occurence Q wave three contiguous lead occurence leave bundle branch block 2 . Culprit lesion eligible percutaneous coronary intervention ( PCI ) 3 . TIMI flow 0 PCI 1 . Fibrinolysis 2 . Allergy morphine 3 . Active epilepsy 4 . Brain injury intracranial hypertension 5 . Previous AMI , coronary artery bypass graft ( CABG ) 6 . Cardiac arrest 7 . Cardiogenic shock , significant mitral regurgitation intraventricular communication inclusion 8 . Mechanical ventilation inclusion 9 . Significant ventricular arrhythmia atrioventricular block type II III inclusion 10 . Decompensated chronic obstructive pulmonary disease inclusion 11. chronic hepatocellular failure 12 . MRI contraindication 13 . Gadolinium chelate injection contraindication 14 . Current treatment morphine chlorhydrate , buprenorphine , nalbuphine , pentazocine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Acute Myocardial Infarction</keyword>
	<keyword>Cardioprotective effect</keyword>
	<keyword>Pharmacological postconditioning</keyword>
	<keyword>Morphine Chlorhydrate</keyword>
	<keyword>Cardiac MRI</keyword>
</DOC>